Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RAD54A Blocking Peptide | Login | RAD54A Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TIGD1 Blocking Peptide | Login | TIGD1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
HNF1 beta Blocking Peptide | Login | HNF1 beta Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Ku70 (AcK539) Blocking Peptide | Login | Ku70 (AcK539) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
NRF2 (AcK599) Blocking Peptide | Login | NRF2 (AcK599) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
NF-kappaB p65 (AcK122) Blocking Peptide | Login | NF-kappaB p65 (AcK122) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
NF-kappaB p65 (AcK218) Blocking Peptide | Login | NF-kappaB p65 (AcK218) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
NF-kappaB p65 Blocking Peptide | Login | NF-kappaB p65 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
p300 Blocking Peptide | Login | p300 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
p300 Blocking Peptide | Login | p300 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
VEGFA Blocking Peptide | Login | VEGFA Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
CD13 Blocking Peptide | Login | CD13 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
CD100 Blocking Peptide | Login | CD100 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
VEGFC Blocking Peptide | Login | VEGFC Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
S100-A1 Blocking Peptide | Login | S100-A1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Plasma Kallikrein HC Blocking Peptide | Login | Plasma Kallikrein HC Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
NF-kappaB p100 Blocking Peptide | Login | NF-kappaB p100 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
CD271 Blocking Peptide | Login | CD271 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Adiponectin Blocking Peptide | Login | Adiponectin Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
VPS34 Blocking Peptide | Login | VPS34 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Calcitonin Blocking Peptide | Login | Calcitonin Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
ACSS1 Blocking Peptide | Login | ACSS1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Beta-catenin Blocking Peptide | Login | Beta-catenin Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Annexin A1 Blocking Peptide | Login | Annexin A1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
VEGFR3 Blocking Peptide | Login | VEGFR3 Blocking Peptide | ||||||||||||||||
|